<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=HDAC6</id>
	<title>HDAC6 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=HDAC6"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=HDAC6&amp;action=history"/>
	<updated>2026-04-25T11:11:30Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=HDAC6&amp;diff=5378622&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=HDAC6&amp;diff=5378622&amp;oldid=prev"/>
		<updated>2024-03-09T22:06:03Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;HDAC6&amp;#039;&amp;#039;&amp;#039; (Histone Deacetylase 6) is a [[enzyme|enzyme]] that in humans is encoded by the &amp;#039;&amp;#039;HDAC6&amp;#039;&amp;#039; [[gene|gene]]. It is a member of the [[histone deacetylase]] family, which is involved in a multitude of cellular processes, such as [[cell cycle|cell cycle progression]], [[gene expression]], and [[protein folding]].&lt;br /&gt;
&lt;br /&gt;
== Function ==&lt;br /&gt;
HDAC6 is unique among the class II HDAC enzymes in that it contains two complete, functional deacetylase domains. This enzyme has been shown to deacetylate [[tubulin]], HSP90, and cortactin, proteins involved in [[cell motility]] and [[vesicle transport]]. It plays a central role in [[microtubule]]-dependent cell motility via the deacetylation of tubulin.&lt;br /&gt;
&lt;br /&gt;
== Clinical significance ==&lt;br /&gt;
HDAC6 has been implicated in a variety of human diseases, including [[cancer]], [[neurodegenerative diseases]], and [[inflammatory diseases]]. In cancer, HDAC6 is frequently overexpressed and has been associated with tumor progression and [[chemotherapy]] resistance. In neurodegenerative diseases, HDAC6 is thought to be involved in the formation of [[aggregated proteins]] and the induction of [[cell death]].&lt;br /&gt;
&lt;br /&gt;
== Inhibitors ==&lt;br /&gt;
Several [[HDAC inhibitors]] have been developed to target HDAC6, including [[tubastatin A]], [[ricolinostat]], and [[ACY-1215]]. These inhibitors have shown promise in preclinical and clinical trials for the treatment of various diseases, particularly cancer.&lt;br /&gt;
&lt;br /&gt;
== See also ==&lt;br /&gt;
* [[Histone deacetylase]]&lt;br /&gt;
* [[HDAC inhibitors]]&lt;br /&gt;
* [[Tubulin]]&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Enzymes]]&lt;br /&gt;
[[Category:Genes]]&lt;br /&gt;
[[Category:Cell biology]]&lt;br /&gt;
[[Category:Medicine]]&lt;br /&gt;
&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>